Navigating the Future of Biotechnology & Life Sciences with Cutting-Edge Insurance Solutions
The biotechnology and life sciences sector has experienced remarkable growth over the past decade, fuelled by technological advancements like AI and the transformative impact of the pandemic. This surge in global demand and investment has created a dynamic landscape where specialised insurance is more crucial than ever.
Why Unique Insurance Needs Matter…
In this fast-evolving field, companies face unique and complex insurance requirements under increasing regulatory scrutiny. That’s why partnering with a specialist insurance broker with deep expertise is essential.
Our team of risk management, legal, and insurance experts has been at the forefront of providing tailored insurance solutions for over 20 years. We see ourselves as an extension of your business, guiding you through every stage from discovery to commercial launch.
Stay Ahead with the Right Broker…
Choosing a broker who truly understands your business is key to maintaining a competitive edge. We offer a proactive approach, leveraging our risk management expertise, insurance market knowledge, and strong relationships with key underwriters to create a robust, adaptable insurance programme.
Five Key Risks Facing Life Sciences Firms:
- Intellectual Property (IP) Infringement – With the high stakes of patent litigation averaging £750,000 in the UK, IP insurance provides critical protection against claims and makes your firm more attractive to investors by demonstrating strong risk management.
- Directors’ and Officers’ (D&O) Liability – Protect the personal assets of your directors and senior managers from claims arising from alleged wrongful actions. D&O insurance covers legal defence costs, compensation, and investigation expenses, often a requirement for investors.
- Bodily Injury from Clinical Trials – Clinical Trials insurance safeguards against liabilities arising from bodily injury, illness, or death of participants, including defence costs.
- Cyber Risk/Breach of Data – In an era where cyberattacks and data breaches are rampant, Cyber Liability Insurance is indispensable. It offers 24/7 technical support, coverage for defence costs, regulatory fines, business income loss, and more. With the average cost of a cyber breach in healthcare hitting £8.8 million in 2023, this protection is vital.
- Generative AI (GenAI) is reshaping the industry, offering transformative potential from drug discovery to personalised patient care. Embracing GenAI can lead to significant efficiency gains and cost savings, however, with this comes new risks. Solutions are available to protect against AI underperformance such as hallucinations, enabling you to turbo charge your investment with the peace of mind that protection is in place should anything go wrong.
Embrace the future with Strategic Growth and Innovation
2025 is set to be a year of strategic acquisitions and collaborations. While economic uncertainties persist, especially in China, the rise in M&A activity and selective venture capital funding for companies with strong data promise exciting opportunities. Public-private partnerships will continue to drive innovation.
Global pharma spending is rising with a shift towards expensive specialty drugs, and governments are implementing price controls that impact innovation. Strategic agility and collaboration are key to navigating this evolving landscape. With advancements in drug development technologies and a focus on globalisation, life sciences companies must adapt to new trade and R&D dynamics. Personalised care and shared decision-making are revolutionising patient experiences and outcomes.
QPI can help support the success of your Biotech by providing expert Risk Management Advice and Insurance Solutions which adapt at every stage.
Ready to explore how specialised insurance solutions can help you thrive?
Contact hayley.dawson@qualitypi.co.uk, or call 07955 270487.
Alternatively send us a quick message below and we will be in touch!
Reference material
2024 Global Life Sciences Sector Outlook